logo

For the Inventor, By the Inventor

Hafnarfjordur, Iceland

Jon Valgeirsson

This inventor holds 6 USPTO granted patents and 16 published patent applications and 2 EPO patents. Top assignee: Actavis Group Ptc Ehf. Active years: 2011-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jon Valgeirsson. Retrieved from https://idiyas.com/inventor/jon-valgeirsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 16.7


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Hafnarfjordur, IE (2011)
  • Hafnarfjorour, IN (2012)
  • Hafnarfjöröur, IS (2013)
  • Hafnarfjordur, IS (2012 - 2015)

Company Filing History:

goldMedal6 out of 13 
 
Actavis Group Ptc Ehf
 patents

Years Active: 2011-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 9006443 - Process for preparing quinoline-3-carboxamide derivatives (2015-04-14),
2. 8552194 - Process for preparing quinoline-3-carboxamide derivatives (2013-10-08),
3. 8354428 - Solid state forms of laquinimod and its sodium salt (2013-01-15),
4. 8101769 - Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide (2012-01-24),
5. 8101597 - Quetiapine salts and their polymorphs (2012-01-24),
6. 7947699 - Anhydrous amorphous imatinib mesylate (2011-05-24),

Title: The Innovative Contributions of Jon Valgeirsson

Introduction

Jon Valgeirsson is a notable inventor based in Hafnarfjordur, Iceland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinoline-3-carboxamide derivatives. With a total of six patents to his name, Valgeirsson's work has had a considerable impact on the industry.

Latest Patents

Valgeirsson's latest patents include an improved, commercially viable, and industrially advantageous process for the preparation of quinoline-3-carboxamide derivatives. This process allows for the production of compounds such as laquinimod, or a pharmaceutically acceptable salt thereof, in high yield and purity. His innovative approach has the potential to enhance the efficiency of pharmaceutical manufacturing.

Career Highlights

Throughout his career, Jon Valgeirsson has worked with prominent companies in the pharmaceutical sector, including Actavis Group PTC EHF. His experience in these organizations has equipped him with the knowledge and skills necessary to drive innovation in drug development.

Collaborations

Valgeirsson has collaborated with several professionals in his field, including Nitin Sharadchandra Pradhan and Girish Dixit. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jon Valgeirsson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…